Global Animal Stem Cell Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Animal Stem Cell Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Animal Stem Cell Therapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Stem Cell Therapy market is projected to reach US$ 482.9 million in 2029, increasing from US$ 203.8 million in 2022, with the CAGR of 12.8% during the period of 2024 to 2029. Demand from Veterinary Hospitals and Research Organizations are the major drivers for the industry.
Global 5 largest manufacturers of Animal Stem Cell Therapy are Ardent Animal Health, VetStem, Medrego, Animal General and Magellan Stem Cells, which make up over 17%. Among them, Ardent Animal Health is the leader with about 6% market share.
Asia Pacific is the largest market, with a share about 50%, followed by North America and Europe, with the share about 26% and 24%. In terms of product type, Dogs Stem Cell Therapy occupies the largest share of the total market, about 47%. And in terms of application, the largest application is Veterinary Hospitals, followed by Research Organizations.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Stem Cell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Veterinary Hospitals
Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal Stem Cell Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Animal Stem Cell Therapy introduction, etc. Animal Stem Cell Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports Conclusions of Animal Stem Cell Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Animal Stem Cell Therapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Stem Cell Therapy market is projected to reach US$ 482.9 million in 2029, increasing from US$ 203.8 million in 2022, with the CAGR of 12.8% during the period of 2024 to 2029. Demand from Veterinary Hospitals and Research Organizations are the major drivers for the industry.
Global 5 largest manufacturers of Animal Stem Cell Therapy are Ardent Animal Health, VetStem, Medrego, Animal General and Magellan Stem Cells, which make up over 17%. Among them, Ardent Animal Health is the leader with about 6% market share.
Asia Pacific is the largest market, with a share about 50%, followed by North America and Europe, with the share about 26% and 24%. In terms of product type, Dogs Stem Cell Therapy occupies the largest share of the total market, about 47%. And in terms of application, the largest application is Veterinary Hospitals, followed by Research Organizations.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Stem Cell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Segment by Application
Veterinary Hospitals
Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal Stem Cell Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Animal Stem Cell Therapy introduction, etc. Animal Stem Cell Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports Conclusions of Animal Stem Cell Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.